Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 28 studies | 36% ± 20% | |
astrocyte | 21 studies | 50% ± 20% | |
oligodendrocyte precursor cell | 16 studies | 44% ± 22% | |
connective tissue cell | 13 studies | 38% ± 15% | |
endothelial cell of artery | 10 studies | 32% ± 14% | |
pericyte | 8 studies | 29% ± 11% | |
glutamatergic neuron | 6 studies | 30% ± 10% | |
endothelial cell | 5 studies | 31% ± 13% | |
abnormal cell | 5 studies | 30% ± 10% | |
myofibroblast cell | 5 studies | 38% ± 13% | |
neuron | 4 studies | 21% ± 3% | |
adventitial cell | 4 studies | 22% ± 3% | |
pancreatic A cell | 3 studies | 50% ± 15% | |
GABAergic neuron | 3 studies | 38% ± 18% | |
interneuron | 3 studies | 32% ± 18% | |
retinal ganglion cell | 3 studies | 39% ± 12% | |
extravillous trophoblast | 3 studies | 55% ± 6% | |
placental villous trophoblast | 3 studies | 21% ± 5% | |
epithelial cell | 3 studies | 23% ± 10% | |
melanocyte | 3 studies | 36% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 8690.91 | 2610 / 2642 | 100% | 121.92 | 702 / 705 |
kidney | 75% | 3838.84 | 67 / 89 | 82% | 93.95 | 736 / 901 |
skin | 46% | 9875.02 | 832 / 1809 | 99% | 979.69 | 467 / 472 |
ovary | 98% | 11133.05 | 177 / 180 | 37% | 14.89 | 160 / 430 |
esophagus | 82% | 4431.28 | 1183 / 1445 | 49% | 26.81 | 90 / 183 |
thymus | 83% | 2812.86 | 541 / 653 | 47% | 14.01 | 284 / 605 |
intestine | 56% | 2180.54 | 542 / 966 | 67% | 28.21 | 355 / 527 |
adrenal gland | 46% | 1071.35 | 118 / 258 | 62% | 43.52 | 143 / 230 |
eye | 0% | 0 | 0 / 0 | 99% | 107.90 | 79 / 80 |
bladder | 57% | 9074.05 | 12 / 21 | 38% | 15.69 | 189 / 504 |
breast | 45% | 1247.81 | 207 / 459 | 48% | 16.79 | 537 / 1118 |
lung | 40% | 1209.38 | 232 / 578 | 47% | 23.06 | 538 / 1155 |
heart | 79% | 4937.04 | 681 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 77% | 4224.80 | 1033 / 1335 | 0% | 0 | 0 / 0 |
stomach | 16% | 502.24 | 58 / 359 | 61% | 23.31 | 174 / 286 |
spleen | 72% | 1449.25 | 173 / 241 | 0% | 0 | 0 / 0 |
uterus | 28% | 639.86 | 47 / 170 | 39% | 17.34 | 179 / 459 |
pancreas | 5% | 76.94 | 15 / 328 | 58% | 24.32 | 104 / 178 |
tonsil | 0% | 0 | 0 / 0 | 60% | 35.80 | 27 / 45 |
prostate | 54% | 2650.08 | 132 / 245 | 3% | 0.72 | 16 / 502 |
adipose | 46% | 1406.93 | 554 / 1204 | 0% | 0 | 0 / 0 |
liver | 4% | 105.74 | 10 / 226 | 20% | 10.11 | 83 / 406 |
lymph node | 0% | 0 | 0 / 0 | 14% | 4.05 | 4 / 29 |
muscle | 3% | 82.67 | 26 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 6.49 | 4 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042177 | Biological process | negative regulation of protein catabolic process |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0033363 | Biological process | secretory granule organization |
GO_0010955 | Biological process | negative regulation of protein processing |
GO_0010951 | Biological process | negative regulation of endopeptidase activity |
GO_0042628 | Biological process | mating plug formation |
GO_0010757 | Biological process | negative regulation of plasminogen activation |
GO_0021683 | Biological process | cerebellar granular layer morphogenesis |
GO_0048711 | Biological process | positive regulation of astrocyte differentiation |
GO_0045879 | Biological process | negative regulation of smoothened signaling pathway |
GO_0051966 | Biological process | regulation of synaptic transmission, glutamatergic |
GO_0090331 | Biological process | negative regulation of platelet aggregation |
GO_0060291 | Biological process | long-term synaptic potentiation |
GO_0030168 | Biological process | platelet activation |
GO_0051898 | Biological process | negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0032940 | Biological process | secretion by cell |
GO_0045861 | Biological process | negative regulation of proteolysis |
GO_0030154 | Biological process | cell differentiation |
GO_0030334 | Biological process | regulation of cell migration |
GO_0030163 | Biological process | protein catabolic process |
GO_0010766 | Biological process | negative regulation of sodium ion transport |
GO_0030195 | Biological process | negative regulation of blood coagulation |
GO_0050974 | Biological process | detection of mechanical stimulus involved in sensory perception |
GO_0061108 | Biological process | seminal vesicle epithelium development |
GO_0060384 | Biological process | innervation |
GO_0030308 | Biological process | negative regulation of cell growth |
GO_0048505 | Biological process | regulation of timing of cell differentiation |
GO_0005615 | Cellular component | extracellular space |
GO_0031091 | Cellular component | platelet alpha granule |
GO_0005576 | Cellular component | extracellular region |
GO_0031594 | Cellular component | neuromuscular junction |
GO_1903561 | Cellular component | extracellular vesicle |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005829 | Cellular component | cytosol |
GO_0008201 | Molecular function | heparin binding |
GO_0004867 | Molecular function | serine-type endopeptidase inhibitor activity |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0005539 | Molecular function | glycosaminoglycan binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SERPINE2 |
Protein name | Serpin family E member 2 Glia-derived nexin (GDN) (Peptidase inhibitor 7) (PI-7) (Protease nexin 1) (PN-1) (Protease nexin I) (Serpin E2) |
Synonyms | PI7 PN1 |
Description | FUNCTION: Serine protease inhibitor with activity toward thrombin, trypsin, and urokinase. Promotes neurite extension by inhibiting thrombin. Binds heparin. |
Accessions | ENST00000432738.5 ENST00000409840.7 [P07093-2] C9JN98 ENST00000258405.9 [P07093-1] ENST00000409304.6 [P07093-2] ENST00000454956.1 ENST00000423446.1 ENST00000447280.6 [P07093-3] P07093 C9JRK5 C9K031 |